Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PYC THERAPEUTICS LIMITED Capital/Financing Update 2014

Jan 2, 2014

65640_rns_2014-01-02_24e34bbf-fd39-460d-a889-57708441a904.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [342 x 73] intentionally omitted <==

3[rd] January 2014

Market Announcements Platform Australian Securities Exchange

Dear Sir

Entitlement Issue Result and Shortfall

Phylogica Limited advises that the Entitlement Offer and Shortfall Offer has concluded with acceptances for 87% of the issue.

acceptances for 87% of the issue.
Shares % of issue
EntitlementAcceptances 233,849,306 58.3
Shortfall Applications less than 1m shares 31,664,802 7.9
Shortfallapplications between 1mand 5mshares 23,305,603 5.8
Shortfall applications more than 5m shares 60,011,803 15.0
Underwriter commitment 51,996,219 13.0
Total issue 400,827,733 100.0

Receipts from shareholders were $5,232,472.70.

The underwriter shortfall commitment amounts to $779,943.30.

Yours faithfully Phylogica Limited

==> picture [139 x 68] intentionally omitted <==

Graeme Boden

Company Secretary

PO Box 8207, Subiaco East, Western Australia 6008 Tel: +61 8 9384 3284 Fax: +61 8 9284 3801 www.phylogica.com ABN 48 098 391 961